SCHEMBL16628770

SCHEMBL16628770

COc1cccc(CN(C)C(=O)c2nc(N)nc3ccccc23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.55
POLB P06746 1/20 0.55
RECQL P46063 1/20 0.55
APP P05067 1/20 0.54
HSD17B2 P37059 5/20 0.54
ROCK1 Q13464 2/20 0.50
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
GBA1 P04062 1/20 0.48
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628815 0.88 ADORA3 (0.58) APPHSD17B2ADORA3ADORA2AMEN1
SCHEMBL3081057 0.86 CYP3A4 (0.53) ADORA3CYP3A4CYP2D6MEN1KMT2A
SCHEMBL16628732 0.86 APP (0.52) HPGDAPPADORA3ADORA2ALMNA
SCHEMBL3090418 0.85 SCD5 (0.52) HPGDAPPADORA2AALDH1A1CYP3A4
SCHEMBL16628737 0.82 TACR1 (0.54) APP
SCHEMBL13144374 0.81 AOC3 (0.46) HSD17B2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL16628767 0.81 CYP3A4 (0.48) HPGDADORA3KDM4EALDH1A1LMNA
SCHEMBL13144375 0.80 ROCK1 (0.47) ROCK1ADORA3ADORA2AKDM4EROCK2
SCHEMBL16628712 0.80 ADORA3 (0.56) APPADORA3ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL16628717 0.79 LMNA (0.50) HPGDLMNAGBA1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed